Mr Jason Low has been appointed as Associate Product Manager (Pharmaceutical) for Singapore with effect from 11 October 2021. Jason brings with him over 6 years of clinical and pharmaceutical experience from the healthcare and pharmaceutical industry, working across organizations such as MSD, Abbott and National Healthcare Group. As a licensed Pharmacist with business acumen, he has played a pivotal role in the launch of multiple brands under the vaccine and anti-infective portfolio, achieving significant quarter on quarter growth during his tenure with MSD.

Mr. Paul Lim has been appointed as Country Head for Singapore and OTC Lead for Singapore, Malaysia and Indonesia with effect from 1st March, 2020. Mr. Lim previously worked at Church & Dwight where he launched and achieved market leadership in numerous countries in the Nasal care and VMS categories as OTC Lead - Asia Pacific.

Mr. Dennis Lim has been appointed as Regulatory Specialist for Singapore with effect from 6 Sep 2021. Prior to joining Wellesta Singapore, Dennis worked as a senior pharmacist in Changi General Hospital where he provided professional clinical pharmacy services to various departments. In particular, he started with specialties including Cardiology, Dermatology, Otorhinolaryngology, Gastroenterology, Ophthalmology, General Medicine, and Renal Medicine, before focusing on Geriatric Medicine, Neurology and Psychiatry.